Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
ECO
Aug 25, 2024, 20:04 |
Blog
Olubukola Ayodele is nominated for a UHL Recognition Award 2024
Olubukola Ayodele posted on LinkedIn: "I am thrilled to share that I have been nominated…
Aug 25, 2024, 15:55 |
Opinion
Elliot Servais: Are you using 3D reconstruction for all pulmonary segmentectomy, some, why, why not?
Elliot Servais, Chief of Thoracic Surgery at Lahey Hospital and Medical Center, shared on X:…
Aug 25, 2024, 08:59 |
Blog
Trials in gynaecological cancers presented at ESTRO24
European Society for Radiotherapy and Oncology (ESTRO) shared on LinkedIn: "Check out the trials in…
Aug 24, 2024, 16:16 |
Blog
Join us Sept. 25 – 27 at online conference for the Ovarian and Gynecologic Cancer community - Ovarian Cancer Research Alliance
Ovarian Cancer Research Alliance shared a post on X: "Join us Sept. 25 – 27 at…
Aug 24, 2024, 14:55 |
Blog
Dana-Farber Cancer Institute celebrates Department of Quality and Patient Safety Staff Recognition Awards
Dana-Farber Cancer Institute shared on LinkedIn: "Oncology care requires stringent regulation and airtight processes to ensure…
Aug 24, 2024, 07:24 |
Insight
Kelcie Willis: Caregivers need more support, but what do patients recommend
Kelcie Willis, Clinical Fellow in Psychology in the Department of Psychiatry at Massachusetts General Hospital,…
Aug 24, 2024, 07:09 |
Blog
Estela Rodriguez: Excited for the Sylvester Comprehensive Cancer Center Cancer Control and Division of Gynecologic Oncology Seminar
Estela Rodriguez shared a post on X: "Excited for this upcoming Sylvester Comprehensive Cancer Center…
Aug 23, 2024, 14:31 |
Blog
CCI4EU second online course on Clinical Trials and Clinical Research - OECI
Organisation of European Cancer Institutes (OECI) shared on LinkedIn: "Don't forget to register for the…
Aug 23, 2024, 14:26 |
Insight
Amol Akhade: Belzutifan vs Everolimus for advanced RCC second line post IO plus TKI
Amol Akhade shared on LinkedIn: "Belzutifan vs Everolimus for advanced RCC second line post IO…
Aug 23, 2024, 05:13 |
Blog
EA5221/ACHIEVE is enrolling older patients with lung cancer - ECOG-ACRIN Cancer Research Group
ECOG-ACRIN Cancer Research Group shared on X: "Clinical Trial EA5221/ACHIEVE, led by Dr. Megan Baumgart…
1
2
3
4
5
All:
4180
Posts:
21 - 30
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 2
Running for a Cure: The Legacy of Terry Fox's Marathon of Hope
How The Breast Cancer Research Foundation was founded
Can Skin Cancer be Prevented by a $0.50 Soap? Meet TIME’s Kid of the Year and His Invention
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube